MUSCLE AND BACK PAIN PLATINUM RELIEF TABLET

Riik: Kanada

keel: inglise

Allikas: Health Canada

Toimeaine:

METHOCARBAMOL; IBUPROFEN

Saadav alates:

VITA HEALTH PRODUCTS INC

ATC kood:

M03BA53

INN (Rahvusvaheline Nimetus):

METHOCARBAMOL, COMBINATIONS EXCL PSYCHOLEPTICS

Annus:

500MG; 200MG

Ravimvorm:

TABLET

Koostis:

METHOCARBAMOL 500MG; IBUPROFEN 200MG

Manustamisviis:

ORAL

Ühikuid pakis:

18/40

Retsepti tüüp:

OTC

Terapeutiline ala:

OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS

Toote kokkuvõte:

Active ingredient group (AIG) number: 0248961001; AHFS:

Volitamisolek:

APPROVED

Loa andmise kuupäev:

2014-03-11

Toote omadused

Page 1 of 41
PRODUCT MONOGRAPH
MUSCLE AND BACK PAIN PLATINUM RELIEF
Methocarbamol and Ibuprofen Caplets
500mg/200mg
Muscle Relaxant/Analgesic
VITA HEALTH PRODUCTS INC. Date of Preparation:
150 Beghin Avenue March 4, 2014
Winnipeg, MB
R2J 3W2 Date of Revision:
December 2, 2019
Control Number 231400
Page 2 of 41
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL
INFORMATION..........................................................3
SUMMARY PRODUCT INFORMATION
...................................................................................3
INDICATIONS AND CLINICAL
USE..........................................................................................3
CONTRAINDICATIONS
..............................................................................................................3
ADVERSE
REACTIONS..............................................................................................................11
DRUG
INTERACTIONS..............................................................................................................13
DOSAGE AND
ADMINISTRATION..........................................................................................16
OVERDOSAGE
...........................................................................................................................16
ACTION AND CLINICAL PHARMACOLOGY
.......................................................................18
STORAGE AND
STABILITY......................................................................................................20
SPECIAL HANDLING INSTRUCTIONS
..................................................................................20
DOSAGE FORMS, COMPOSITION AND PACKAGING
........................................................21
PART II: SCIENTIFIC
INFORMATION................................................................................22
PHARMACEUTICAL
INFORMATION......................................................................................22
CLINICAL
TRIALS..................................................